Recombinant Human Fibroblast Growth Factor Receptor 2, Fc Chimera
Cat.No. : | FGFR2-595H |
Product Overview : | Recombinant human soluble FGFR-2á (IIIc) was fused via a Xa cleavage site with the Fc part of human IgG1. Human recombinant soluble FGFR-2á (IIIc) is a disulfide-linked heterodimeric protein. The reduced form of human FGF -R2á (IIIc)/Fc is a monomer with a calculated molecular mass of approximately 66 kDa. As a result of glycosylation, the recombinant protein has a mass of 95-100 kDa. It is produced inE.coli. |
- Specification
- Gene Information
- Related Products
Cat. No. : | FGFR2-595H |
Description : | Fibroblast Growth Factors (FGFs) comprise a family of at least eighteen structurally realted proteins that are involved in a multitude of physiological and pathological cellular processes, including cell growth, differentation, angiogenesis, wound healing and tumorgenesis. The biological activities of the FGFs are mediated by a family if type I transmembrane tyrosine kinases which undergo dimerization and autophosphorylation after ligand binding. Four distinct genes encoding closely related FGF receptors, FGFR-1to -4 are known. Multiple forms of FGFR-1 to -3 are generated by alternative splicing of the mRNAs. A frequent splicing event involving FGFR-1 and -2 results in receptors containing all three Ig domains, referred to as the á isoform, or only IgII and IgIII, referred to as the ß isoform. Only the á isoform has been identified for FGFR-3 and FGFR-4. |
Source : | E.coli. |
Subunit : | Glycosylated dimer. |
Formulation : | Lyophilized. |
Endotoxin Level : | < 0.1 ng per ug of sFGF-R2á. |
Purity : | > 90%, by SDS-PAGE and visualised by silver stain. |
Reconstitution : | The lyophilised sFGFR-2á (IIIc)/Fc is soluble in water and most aqueous buffers. The lyophilised sFGF-R2á (IIIc)/Fc should be reconstituted in PBS or medium to a concentration not l lower than 50µg/ml. |
Biological Activity : | Determined by its ability to inhibit human FGF acidic-dependent proliferation on R1 cells. The ED50 for this effect is typically at 15.0-30.0 ng/ml. |
Stability : | Lyophilised samples are stable for greater than six months at –20°C to –70℃. Reconstituted sFGFR-2á (IIIc)/Fc should be stored in working aliquots at -20℃. Avoid repeated freeze-thaw cycles! |
Gene Name : | FGFR2 fibroblast growth factor receptor 2 [ Homo sapiens ] |
Synonyms : | FGFR2; fibroblast growth factor receptor 2; BEK; JWS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FLJ98662; BEK fibroblast growth factor receptor; FGF receptor; OTTHUMP00000020624; OTTHUMP00000020626; bacteria-expressed kinase; hydroxyaryl-protein kinase; keratinocyte growth factor receptor; protein tyrosine kinase, receptor like 14; soluble FGFR4 variant 4; EC 2.7.10.1 |
Gene ID : | 2263 |
mRNA Refseq : | NM_000141 |
Protein Refseq : | NP_000132 |
MIM : | 176943 |
UniProt ID : | P21802 |
Chromosome Location : | 10q26 |
Pathway : | Endocytosis; MAPK signaling pathway; Pathways in cancer; Prostate cancer; Regulation of actin cytoskeleton; Signaling by FGFR |
Function : | ATP binding; fibroblast growth factor receptor activity; heparin binding; nucleotide binding; receptor activity; transferase activity |
Products Types
◆ Recombinant Protein | ||
FGFR2-33H | Recombinant Active Human FGFR2 (M420I) Protein (285-end), N-GST-tagged | +Inquiry |
FGFR2-2055H | Recombinant Human FGFR2 Protein, DDK-tagged | +Inquiry |
Fgfr2-135M | Recombinant Mouse Fgfr2 Protein, His (Fc)-Avi-tagged | +Inquiry |
FGFR2-5418H | Recombinant Human Fibroblast Growth Factor Receptor 2, His-tagged | +Inquiry |
FGFR2-4128H | Recombinant Human FGFR2 Protein | +Inquiry |
◆ Lysates | ||
FGFR2-428HCL | Recombinant Human FGFR2 cell lysate | +Inquiry |
FGFR2-2578HCL | Recombinant Human FGFR2 cell lysate | +Inquiry |
◆ Assay kits | ||
Kit-0341 | FGFR2 Kinase (Human) Assay/Inhibitor Screening Assay Kit | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionMutations in FGFR2 are associated with various developmental disorders, impacting the development of the skull, limbs, and other structures.
Yes, targeting FGFR2 mutations allows for more personalized and precise therapeutic approaches in cancer treatment.
Yes, numerous clinical trials are underway to evaluate the efficacy of FGFR2 inhibitors in treating various cancers and developmental disorders.
FGFR2 is involved in the regulation of cell migration and tissue repair, contributing to the process of wound healing.
Common side effects of FGFR2 inhibitors include fatigue, nausea, and hypertension, which are being studied for better management.
Customer Reviews (3)
Write a reviewThe FGFR2 protein is an outstanding product that possesses exceptional quality, making it an ideal choice for my experimental needs.
What sets FGFR2 apart is the manufacturer's unparalleled technical support.
The versatility of the FGFR2 protein makes it a valuable asset in my research.
Ask a Question for All FGFR2 Products
Required fields are marked with *
My Review for All FGFR2 Products
Required fields are marked with *
Inquiry Basket